Circular economy: Focus on anti-microbial resistance through public policy

We co-signed the Investor Action on Antimicrobial Resistance (IAAMR) Public Investor Statement, which was coordinated by Access to Medicine Foundation, FAIRR initiative and the UK Department of Health and Social Care, alongside 80 investor signatories representing US$13 trillion. It called for global leaders and policymakers to reinvigorate efforts, coordinate action, and reaffirm their commitments on AMR ahead of the UN General Assembly’s second High-Level Meeting (HLM) on AMR. The HLM resulted in the adoption of an extended Political Declaration. Commitments were made around reducing human deaths associated with AMR by 10% by 2030. It called for sustainable financing on national action plans on AMR, the development of alternative treatments such as vaccines, and the promotion of responsible use in animal health.